Newsletter | April 26, 2024

04.26.24 -- A Quality-Led Approach To Drug Production Facility Design

SPONSOR

Outsourced Pharma Capacity Update covers the entire pharmaceutical product formulation, manufacturing, and packaging spectrum, emphasizing process development and GMP compliance. Explore innovative solutions from CDMOs with capacity during our new PARTNER WEEK for solid orals, liquid orals, semi-solid, and specialty dosage forms. Register today for the Small Molecule Finished Dosage Form session happening May 22nd.

FEATURED EDITORIAL

A Quality-Led Approach To Drug Production Facility Design

There are important considerations that architects and engineers can miss if they don't include the quality perspective. It's better to involve quality at the outset rather than discover omissions when it's too late.

INDUSTRY INSIGHTS

Nasal Vaccine Development, Manufacturing, And Device Selection

When developing a nasal delivery program, a partner with experience in development and manufacturing techniques who can see a program through small-scale clinical to commercial supply is crucial.

Simultaneous Spray Drying For Combination Dry Powder Inhaler Formulations

Three combination case studies are demonstrated in which bevacizumab is paired with erlotinib, cisplatin, or paclitaxel in a dry powder inhaler formulation.

Validated LC–MS/MS Method For The Determination Of Copanlisib

Review findings on a validated LC–MS/MS method for quantifying copanlisib from a dried blood spot and its potential for enabling desirable sensitivity, accuracy, and precision.

Breaking Bad Manufacturing Habits: Attaining Sustainable API Production

Sustainability is a growing issue in the pharmaceutical industry. Review strategies for reducing your carbon footprint and learn how the right CDMO can help drive the sustainable manufacture of APIs.

Outsourcing High Potent OSD Late-Stage Development: CDMO Insights

View the webinar to discover outsourcing options for highly potent oral solid dose therapies, and learn how CDMOs can transfer, handle and deliver their product to clinic and to market.

SPONSOR

Latest Advances In Applied Nanotechnology For Formulating Better Amorphous Solid Dispersions and Monoclonal Antibodies 

Join us on May 1st to learn the latest in nanotechnology. Recent developments in leading nanotechnologies are enabling new formulation possibilities for more products, providing a better patient experience and stronger differentiation for biopharma innovators. Discover new data on nanotechnology and how to tackle drug loading and pill burden issues associated with amorphous solid dispersion formulations. Click here to learn more.

SOLUTIONS

PBPK Predictive Modeling Services

Early identification of potential absorption risks is critical for rapid and efficient drug development. Lonza's PBPK modeling services are designed to de-risk your drug development program.

Capacity Update February 2024: Small Molecule

Societal provides development, regulatory support, clinical and commercial manufacturing, packaging, and logistics services. Delve into Societal’s capabilities and open capacity across sites.

OUTSOURCED PHARMA CAPACITY UPDATE

Find Your New CDMO At Outsourced Pharma Capacity Update

CDMOs in biologics, cell and gene, and small molecule share their capabilities and available capacities. See for yourself why this virtual event has become a wildly popular resource to identify options for your development and manufacturing needs.

Connect With Outsourced Pharma: